Rongrong Mao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rongrong Mao has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Dafu Yu
Department of Nuclear Medicine, First People’s Hospital of Yunnan Province Kunming, China
1 shared publicationDongli Wang
Chronic Disease Control and Prevention Center, Shenzhen Guangming District Center for Disease Control and Prevention, Shenzhen, China
1 shared publication- Heng Zhou
Jiangsu Key Laboratory of Brain Disease Bioinformation, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
1 shared publication - Hongyan Liu
College of Electronic Science and Technology, National University of Defense Technology, Changsha 410073, China
1 shared publication - Huaitie Xiao
National Key Laboratory of Automatic Target Recognition, National University of Defense Technology, Changsha, China
1 shared publication Jinbo Lin
Medical Oncology, Longgang District Central Hospital of Shenzhen
1 shared publication
Latest Publications
- 7 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 23 (24) , 30786-30793
Electromagnetic Vortex Imaging Based on OAM Multiplexing Beam With Orthogonal Polyphase Coding
The doughnut-shaped radiation energy pattern of orbital angular momentum (OAM) beams has been a longstanding challenge in electromagnetic (EM) vortex imaging. In this paper, an effective EM vortex imaging scheme is developed based on the orthogonal polyphase-coded OAM multiplexing beam with mitigated beam energy divergence. Firstly, vortex EM waves are modulated with different orthogonal polyphase codes and transmitted simultaneously to illuminate the imaging scenario. The codes change the phase relationship between different transmitted signals, leading to a convergent energy distribution around the beam axis. Then, an OAM demultiplexing method is proposed to separate the radar echo of each OAM mode, which maintains the individual spiral phase fronts at the same time. Finally, the two-dimensional fast Fourier transform (FFT) is applied to the demodulated signals to reconstruct the target image. Simulation results show that the proposed imaging method has a higher azimuth resolution than the traditional method with small elevation angles and performs much better in low SNR environments. Furthermore, an experiment in an anechoic chamber validates the potential of the proposed method. This work can benefit the practical applications of OAM imaging technology.
- 7 November 2023
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Sensors Journal
- Vol. 23 (24) , 30786-30793
Electromagnetic Vortex Imaging Based on OAM Multiplexing Beam With Orthogonal Polyphase Coding
The doughnut-shaped radiation energy pattern of orbital angular momentum (OAM) beams has been a longstanding challenge in electromagnetic (EM) vortex imaging. In this paper, an effective EM vortex imaging scheme is developed based on the orthogonal polyphase-coded OAM multiplexing beam with mitigated beam energy divergence. Firstly, vortex EM waves are modulated with different orthogonal polyphase codes and transmitted simultaneously to illuminate the imaging scenario. The codes change the phase relationship between different transmitted signals, leading to a convergent energy distribution around the beam axis. Then, an OAM demultiplexing method is proposed to separate the radar echo of each OAM mode, which maintains the individual spiral phase fronts at the same time. Finally, the two-dimensional fast Fourier transform (FFT) is applied to the demodulated signals to reconstruct the target image. Simulation results show that the proposed imaging method has a higher azimuth resolution than the traditional method with small elevation angles and performs much better in low SNR environments. Furthermore, an experiment in an anechoic chamber validates the potential of the proposed method. This work can benefit the practical applications of OAM imaging technology.
- Open Access
- 31 July 2017
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 11, 223
Hippocampal Administration of Levothyroxine Impairs Contextual Fear Memory Consolidation in Rats
Thyroid hormone (TH) receptors are highly distributed in the hippocampus, which plays a vital role in memory processes. However, how THs are involved in the different stages of memory process is little known. Herein, we used hippocampus dependent contextual fear conditioning to address the effects of hippocampal THs on the different stages of fear memory. First, we found that a single systemic levothyroxine (LT4) administration increased the level of free triiodothyronine (FT3) and free tetraiodothyroxine (FT4) not only in serum but also in hippocampus. In addition, a single systemic LT4 administration immediately after fear conditioning significantly impaired fear memory. These results indicated the important role of hippocampal THs in fear memory process. To further confirm the effects of hippocampal THs on the different stages of fear memory, LT4 (0.4 μg/μl, 1 μl/side) was injected bilaterally into hippocampus. Rats given LT4 into hippocampus before training or tests had no effect on the acquisition or retrieval of fear memory, however rats given LT4 into hippocampus either immediately or 2 h after training showed being significantly impaired fear memory, which demonstrated LT4 administration into hippocampus impairs the consolidation but has no effect on the acquisition and retrieval of fear memory. Furthermore, hippocampal injection of LT4 did not affect rats’ locomotor activity, thigmotaxis and THs level in prefrontal cortex (PFC) and serum. These findings may have important implications for understanding mechanisms underlying contribution of THs to memory disorders.
- 31 July 2017
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 11, 223
Open AccessHippocampal Administration of Levothyroxine Impairs Contextual Fear Memory Consolidation in Rats
Thyroid hormone (TH) receptors are highly distributed in the hippocampus, which plays a vital role in memory processes. However, how THs are involved in the different stages of memory process is little known. Herein, we used hippocampus dependent contextual fear conditioning to address the effects of hippocampal THs on the different stages of fear memory. First, we found that a single systemic levothyroxine (LT4) administration increased the level of free triiodothyronine (FT3) and free tetraiodothyroxine (FT4) not only in serum but also in hippocampus. In addition, a single systemic LT4 administration immediately after fear conditioning significantly impaired fear memory. These results indicated the important role of hippocampal THs in fear memory process. To further confirm the effects of hippocampal THs on the different stages of fear memory, LT4 (0.4 μg/μl, 1 μl/side) was injected bilaterally into hippocampus. Rats given LT4 into hippocampus before training or tests had no effect on the acquisition or retrieval of fear memory, however rats given LT4 into hippocampus either immediately or 2 h after training showed being significantly impaired fear memory, which demonstrated LT4 administration into hippocampus impairs the consolidation but has no effect on the acquisition and retrieval of fear memory. Furthermore, hippocampal injection of LT4 did not affect rats’ locomotor activity, thigmotaxis and THs level in prefrontal cortex (PFC) and serum. These findings may have important implications for understanding mechanisms underlying contribution of THs to memory disorders.
- Open Access
- 1 June 2017
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 3193-3201
The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis
Purpose: Abnormal expression of miR-223 in cancerous tissue has confirmed it as an important player in tumorigenesis of cancers, such as hepatocellular carcinoma, colorectal carcinoma, osteosarcoma, gastric cancer, and chronic lymphocytic leukemia. The present meta-analysis aimed to explore the association between circulating miR-223 and prognosis of cancers. Methods: The studies were accessed by an electronic search of multiple databases. RevMan5.3 and STATA14.0 were used to estimate the heterogeneity among studies, pooled effects, and publication bias. Results: Ten studies with data of 1,002 patients with cancer were included in this meta-analysis. The risk of metastasis from stages 3 to 4 of TNM did not decrease when high versus low circulating expression of miR-223 were compared (pooled odds ratio =0.50, 95% CI: 0.24–1.03). In case of prognosis, the overall survival time was not significantly longer with high circulating miR-223 expression (pooled hazard ratio [HR] =0.64, 95% CI: 0.38–1.11) in all cancer types. However, the overall survival time of chronic lymphocytic leukemia (pooled HR =0.19, 95% CI: 0.07–0.54) increased in subgroup analysis. Moreover, the treatment-free survival of chronic lymphocytic leukemia was significantly increased with high circulating miR-223 expression (pooled HR =0.38, 95% CI: 0.23–0.64). Conclusion: Circulating miR-223 was not an effective biomarker in prognosis surveillance in all cancers but in chronic lymphocytic leukemia.
- 1 June 2017
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 10, 3193-3201
Open AccessThe effect of circulating miR-223 on surveillance of different cancers: a meta-analysis
Purpose: Abnormal expression of miR-223 in cancerous tissue has confirmed it as an important player in tumorigenesis of cancers, such as hepatocellular carcinoma, colorectal carcinoma, osteosarcoma, gastric cancer, and chronic lymphocytic leukemia. The present meta-analysis aimed to explore the association between circulating miR-223 and prognosis of cancers. Methods: The studies were accessed by an electronic search of multiple databases. RevMan5.3 and STATA14.0 were used to estimate the heterogeneity among studies, pooled effects, and publication bias. Results: Ten studies with data of 1,002 patients with cancer were included in this meta-analysis. The risk of metastasis from stages 3 to 4 of TNM did not decrease when high versus low circulating expression of miR-223 were compared (pooled odds ratio =0.50, 95% CI: 0.24–1.03). In case of prognosis, the overall survival time was not significantly longer with high circulating miR-223 expression (pooled hazard ratio [HR] =0.64, 95% CI: 0.38–1.11) in all cancer types. However, the overall survival time of chronic lymphocytic leukemia (pooled HR =0.19, 95% CI: 0.07–0.54) increased in subgroup analysis. Moreover, the treatment-free survival of chronic lymphocytic leukemia was significantly increased with high circulating miR-223 expression (pooled HR =0.38, 95% CI: 0.23–0.64). Conclusion: Circulating miR-223 was not an effective biomarker in prognosis surveillance in all cancers but in chronic lymphocytic leukemia.